期刊文献+

结直肠癌组织BCL9和VEGF的表达与临床意义 被引量:2

The Expression of BCL9 and VEGF in Colorectal Cancer and Their Clinical Significance
下载PDF
导出
摘要 探讨结直肠癌中B细胞淋巴瘤因子9(B-cell lymphoma 9,BCL9)和血管内皮生长因子(vascular endothelial growth factor,VEGF)表达与临床病理的关系及其临床意义.采用免疫组织化学SABC染色法,检测83例结直肠癌组织和10例癌旁正常组织中BCL9及VEGF蛋白的表达情况,并且分析其与临床病理特征的关系.BCL9和VEGF在癌组织中表达率分别为67.47%(56/83)和69.88%(58/83),而癌旁正常组织中均不表达.BCL9在结直肠癌中的表达与肿瘤分化程度、浸润深度、Dukes分期、有无淋巴结转移相关(P<0.05).VEGF在结直肠癌中的表达与肿瘤分化程度、浸润深度无关,而与肿瘤Dukes分期、有无淋巴结转移密切相关(P<0.01).结直肠癌中VEGF的表达随BCL9表达的升高而升高(P<0.01).BCL9、VEGF可能在结肠癌的发生发展过程中起重要作用.BCL9可能通过上调VEGF的表达,促进肿瘤浸润和转移. To explore the relationship between the expression of B-cell lymphoma 9(BCL9)and vascular endothelial growth factor(VEGF)in colorectal cancer and their clinical pathological features,and their clinical significance.Immunohistochemistry SABC method was used to detect the expression of BCL9 and VEGF in 83 cases of colorectal carcinomas and 10 cases of cancer adjacent normal tissue,and the relationship between protein expression and clinical pathological features was analyzed.The expression rate of BCL9 and VEGF protein in cancer tissue were 67.47%(56/83)and 69.88%(58/83),respectively.While both had no expression in cancer adjacent normal tissue.The BCL9 expression was correlated with differentiation degree,depth of infiltration,Dukes stage and lymph node metastasis(P 0.05).There was no correlation between the VEGF expression and differentiation degree,depth of infiltration,but that was closely correlated with Dukes stage and lymph node metastasis(P0.01).The expression of VEGF increased with BCL9(P0.01).BCL9 and VEGF may play an important role in development of colorectal carcinoma.The tumor invasion and metastasis may be promoted by BCL9 which works by up-regulating the expression of VEGF.
出处 《生命科学研究》 CAS CSCD 2010年第3期246-249,共4页 Life Science Research
关键词 结直肠肿瘤 细胞淋巴瘤因子9(BCL9) 血管内皮生长因子(VEGF) 免疫组化 治疗新靶点 colorectal carcinoma B-cell lymphoma 9(BCL9) vascular endothelial growth factor(VEGF) immunohistochemistry a new target for therapy
  • 相关文献

参考文献11

  • 1POLAKIS P.Wnt signaling and cancer[J].GenesDev,2000,14(15):1837-1851.
  • 2KRAMPS T,PETER O,BRUNNER E,et al.Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclearβ-Catenin-TCF complex[J].Cell,2002,109(1):47-60.
  • 3DE LA ROCHE M,W ORM J,BIENZ M.The function of BCL9 in Wnt/β-catenin signaling and colorectal cancer cells[J].BMC Cancer,2008,199(8):1-13.
  • 4SUSTMANN C,FLACH H,EASTMAN Q,et al.Cell-typespecific function of BCL9 involves a transcriptional activation domain that synergizes with β-catenin[J].Molecular and Cellular Biology,2008,28(10):3526-3537.
  • 5MALA M,DANIEL E C,KOHICHI T,et al.BCL9 promotes tumor progression by conferrng enhanced proliferative,metastatic,and angiogenic properties to cancer cells[J].Cancer Res,2009,69(19):1-10.
  • 6BERNSTEIN C,BERNSTEIN H,PAYNE C M,et al.Field defects in progression to gastrointestinal tract cancers[J].Cancer Lett,2008,260(1-2):1-10.
  • 7SAKAMOTO I,OHWADA S,TOYA H,et al.Up-regulation of a BCL9-related β-catenin-binding protein,B9L,in different stages of sporadic colorectal adenoma[J].Cancer Sci,2007,98(1):83-87.
  • 8CORBIN M,AURELIEN D R,DAVID S R,et al.WNT/β-catenin pathway activation in wilms tumors:a unifying mechanism with multiple entries?[J].Genes,Chromosomes & Cancer,2009,48(9):816-827.
  • 9TOYA H,OYAMA T,OHWADA S,et al.Immunohistochemical expression of the β-catenin-interacting protein B9L is associated with histological high nuclear grade and immunohistochemical ErbB2/HER-2 expression in breast cancers[J].Cancer Sci,2007,98(4):484-490.
  • 10WILLIS T G,ZALCBERG I R,COIGNET L J A,et al.Molecular cloning of translocation t(1; 14) (q21; q32) defines a novel gene(BCL9) at chromosome 1q21[J].Blood,1998,91(6):1873-1881.

同被引文献54

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部